AI Verdict
NTNX has stronger fundamentals based on our AI analysis.
NTNX vs NTLA Fundamental Comparison
| Metric | NTNX | NTLA |
|---|---|---|
| Revenue | $1.4B | $67.7M |
| Net Income | $165.1M | $-412.7M |
| Net Margin | 11.8% | -609.9% |
| ROE | N/A | -61.5% |
| ROA | 5.0% | -49.0% |
| Current Ratio | 1.65x | 5.08x |
| Debt/Equity | N/A | 0.00x |
| EPS | $0.57 | $-3.81 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NTNX vs NTLA: Frequently Asked Questions
Is NTNX or NTLA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NTNX has stronger fundamentals. NTNX is rated BUY (72% confidence) while NTLA is rated SELL (92% confidence). This is not investment advice.
How does NTNX compare to NTLA fundamentally?
Nutanix, Inc. has ROE of N/A vs Intellia Therapeutics, Inc.'s -61.5%. Net margins are 11.8% vs -609.9% respectively.
Which stock pays higher dividends, NTNX or NTLA?
NTNX has a dividend yield of N/A or no dividend while NTLA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NTNX or NTLA for long term?
For long-term investing, consider that NTNX has BUY rating with 72% confidence, while NTLA has SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NTNX vs NTLA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NTNX vs NTLA, the AI consensus favors NTNX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.